0001373604-24-000035.txt : 20240613
0001373604-24-000035.hdr.sgml : 20240613
20240613180427
ACCESSION NUMBER: 0001373604-24-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leonard Braden Michael
CENTRAL INDEX KEY: 0001373603
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 241042432
MAIL ADDRESS:
STREET 1: 156 S. FIRST STREET
CITY: ZIONSVILLE
STATE: IN
ZIP: 46077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 LEE ROAD
STREET 2: SUITE 103
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 701 LEE ROAD
STREET 2: SUITE 103
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
form4.xml
X0508
4
2024-06-11
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001373603
Leonard Braden Michael
65 E CEDAR - SUITE 2
ZIONSVILLE
IN
46077
true
false
Common Stock
2024-06-11
4
P
0
1000000
1.08
A
10395934
I
Holding of BML Investment Partners, L.P.
Common Stock
2024-06-12
4
P
0
82579
1.14
A
10478513
I
Holding of BML Investment Partners, L.P.
Common Stock
2024-06-13
4
P
0
28621
1.1445
A
10507134
I
Holding of BML Investment Partners, L.P.
Common Stock
2024-06-13
4
P
0
500000
1.15
A
11007134
I
Holding of BML Investment Partners, L.P.
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.14 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.1445 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Braden Michael Leonard
2024-06-13